Clinical Trial Update: Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)

View source ↗

Summary

Clinical trial SITAR evaluated switching from sildenafil to tadalafil in patients with pulmonary arterial hypertension. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Adcirca (tadalafil)
• REVATIO (SILDENAFIL CITRATE)

Snippet

Sponsor: Mayo Clinic | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED